David Philip Bloxham
Technik-/Wissenschafts-/F&E-Leiter bei Celltech Group Ltd.
Profil
David Philip Bloxham is currently the Director of Research & Development at Celltech Group Ltd.
He previously held positions as Chairman at Evolutec Group Plc and The Babraham Institute, and as a Non-Executive Director at Cobra Biologics Holdings Ltd.
From 2011 to 2015, he served as an Independent Non-Executive Director at Ark Therapeutics Group Plc.
Bloxham earned a doctorate degree from The University of Southampton in 1971.
Aktive Positionen von David Philip Bloxham
Unternehmen | Position | Beginn |
---|---|---|
Celltech Group Ltd.
Celltech Group Ltd. Financial ConglomeratesFinance Part of UCB SA, Celltech Group Ltd. is an investment holding British company. The company is based in Slough, UK. Celltech Group was founded in 1987. | Technik-/Wissenschafts-/F&E-Leiter | - |
Ehemalige bekannte Positionen von David Philip Bloxham
Unternehmen | Position | Ende |
---|---|---|
Ark Therapeutics Group Plc
Ark Therapeutics Group Plc Miscellaneous Commercial ServicesCommercial Services Ark Therapeutics Group Plc is a gene-based medicine company, which is engaged in the discovery, development and commercialization of products in areas of specialist medicine, with particular focus on vascular disease and cancer. The company was founded by Peter Stephen Keen, John W. Martin, Seppo Ylä-Herttuala, Stephen Barker and Kenneth Powell in July 1997 and is headquartered in London, the United Kingdom. | Direktor/Vorstandsmitglied | 27.02.2015 |
Evolutec Group Plc
Evolutec Group Plc BiotechnologyHealth Technology Evolutec Group Plc is an biopharmaceutical company, which discovers and develops novel biopharmaceuticals for allergic, anti-inflammatory and auto-immune diseases. It was founded in1998 and headquartered in Oxford, United Kingdom. | Vorsitzender | 04.05.2009 |
Cobra Biologics Holdings Ltd.
Cobra Biologics Holdings Ltd. BiotechnologyHealth Technology Cobra Biomanufacturing Plc manufactures biological products for clinical studies and clients in the pharmaceutical and biotech industries. It designs and manufactures novel proteins, viruses and additional cell products. It provides DNA-based technologies, services and products. Its services include: DNA, virus and protein manufacturing, cell banking, process development, analytical services and quality assurance and regulatory support. It uses mammalian and microbial host cells for numerous therapeutic protein developments. It also provides a range of DNA maintenance technology, such as its ORT, ORT-VAC and RiboCLEAR programs. The company is headquartered in Newcastle, the United Kingdom. | Direktor/Vorstandsmitglied | 01.09.2006 |
The Babraham Institute
The Babraham Institute Miscellaneous Commercial ServicesCommercial Services Babraham Institute operates as charitable life sciences organization. It is a registered charity, sponsored by the Biotechnology and Biological Sciences Research Council. Babraham Institute is headquartered in Cambridge, GB. | Vorsitzender | - |
Ausbildung von David Philip Bloxham
The University of Southampton | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 5 |
---|---|
Cobra Biologics Holdings Ltd.
Cobra Biologics Holdings Ltd. BiotechnologyHealth Technology Cobra Biomanufacturing Plc manufactures biological products for clinical studies and clients in the pharmaceutical and biotech industries. It designs and manufactures novel proteins, viruses and additional cell products. It provides DNA-based technologies, services and products. Its services include: DNA, virus and protein manufacturing, cell banking, process development, analytical services and quality assurance and regulatory support. It uses mammalian and microbial host cells for numerous therapeutic protein developments. It also provides a range of DNA maintenance technology, such as its ORT, ORT-VAC and RiboCLEAR programs. The company is headquartered in Newcastle, the United Kingdom. | Health Technology |
Evolutec Group Plc
Evolutec Group Plc BiotechnologyHealth Technology Evolutec Group Plc is an biopharmaceutical company, which discovers and develops novel biopharmaceuticals for allergic, anti-inflammatory and auto-immune diseases. It was founded in1998 and headquartered in Oxford, United Kingdom. | Health Technology |
Ark Therapeutics Group Plc
Ark Therapeutics Group Plc Miscellaneous Commercial ServicesCommercial Services Ark Therapeutics Group Plc is a gene-based medicine company, which is engaged in the discovery, development and commercialization of products in areas of specialist medicine, with particular focus on vascular disease and cancer. The company was founded by Peter Stephen Keen, John W. Martin, Seppo Ylä-Herttuala, Stephen Barker and Kenneth Powell in July 1997 and is headquartered in London, the United Kingdom. | Commercial Services |
The Babraham Institute
The Babraham Institute Miscellaneous Commercial ServicesCommercial Services Babraham Institute operates as charitable life sciences organization. It is a registered charity, sponsored by the Biotechnology and Biological Sciences Research Council. Babraham Institute is headquartered in Cambridge, GB. | Commercial Services |
Celltech Group Ltd.
Celltech Group Ltd. Financial ConglomeratesFinance Part of UCB SA, Celltech Group Ltd. is an investment holding British company. The company is based in Slough, UK. Celltech Group was founded in 1987. | Finance |